Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:20810734rdf:typepubmed:Citationlld:pubmed
pubmed-article:20810734lifeskim:mentionsumls-concept:C0887913lld:lifeskim
pubmed-article:20810734lifeskim:mentionsumls-concept:C0300423lld:lifeskim
pubmed-article:20810734lifeskim:mentionsumls-concept:C0225336lld:lifeskim
pubmed-article:20810734lifeskim:mentionsumls-concept:C0078058lld:lifeskim
pubmed-article:20810734lifeskim:mentionsumls-concept:C0013081lld:lifeskim
pubmed-article:20810734lifeskim:mentionsumls-concept:C1332729lld:lifeskim
pubmed-article:20810734lifeskim:mentionsumls-concept:C1171892lld:lifeskim
pubmed-article:20810734lifeskim:mentionsumls-concept:C0205263lld:lifeskim
pubmed-article:20810734lifeskim:mentionsumls-concept:C0173022lld:lifeskim
pubmed-article:20810734pubmed:issue21lld:pubmed
pubmed-article:20810734pubmed:dateCreated2010-10-8lld:pubmed
pubmed-article:20810734pubmed:abstractTextHantavirus pulmonary syndrome (HPS) and hemorrhagic fever with renal syndrome (HFRS) are severe diseases associated with hantavirus infection. High levels of virus replication occur in microvascular endothelial cells but without a virus-induced cytopathic effect. However, virus infection results in microvascular leakage, which is the hallmark of these diseases. VE-cadherin is a major component of adherens junctions, and its interaction with the vascular endothelial growth factor (VEGF) receptor, VEGF-R2, is important for maintaining the integrity of the endothelial barrier. Here we report that increased secreted VEGF and concomitant decreased VE-cadherin are seen at early times postinfection of human primary lung endothelial cells with an HPS-associated hantavirus, Andes virus. Furthermore, active virus replication results in increased permeability and loss of the integrity of the endothelial cell barrier. VEGF binding to VEGF-R2 is known to result in dissociation of VEGF-R2 from VE-cadherin and in VE-cadherin activation, internalization, and degradation. Consistent with this, we showed that an antibody which blocks VEGF-R2 activation resulted in inhibition of the Andes virus-induced VE-cadherin reduction. These data implicate virus induction of VEGF and reduction in VE-cadherin in the endothelial cell permeability seen in HPS and suggest potential immunotherapeutic targets for the treatment of the disease.lld:pubmed
pubmed-article:20810734pubmed:languageenglld:pubmed
pubmed-article:20810734pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:20810734pubmed:citationSubsetIMlld:pubmed
pubmed-article:20810734pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:20810734pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:20810734pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:20810734pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:20810734pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:20810734pubmed:statusMEDLINElld:pubmed
pubmed-article:20810734pubmed:monthNovlld:pubmed
pubmed-article:20810734pubmed:issn1098-5514lld:pubmed
pubmed-article:20810734pubmed:authorpubmed-author:RollinPierre...lld:pubmed
pubmed-article:20810734pubmed:authorpubmed-author:SpiropoulouCh...lld:pubmed
pubmed-article:20810734pubmed:authorpubmed-author:Shrivastava-R...lld:pubmed
pubmed-article:20810734pubmed:issnTypeElectroniclld:pubmed
pubmed-article:20810734pubmed:volume84lld:pubmed
pubmed-article:20810734pubmed:ownerNLMlld:pubmed
pubmed-article:20810734pubmed:authorsCompleteYlld:pubmed
pubmed-article:20810734pubmed:pagination11227-34lld:pubmed
pubmed-article:20810734pubmed:meshHeadingpubmed-meshheading:20810734...lld:pubmed
pubmed-article:20810734pubmed:meshHeadingpubmed-meshheading:20810734...lld:pubmed
pubmed-article:20810734pubmed:meshHeadingpubmed-meshheading:20810734...lld:pubmed
pubmed-article:20810734pubmed:meshHeadingpubmed-meshheading:20810734...lld:pubmed
pubmed-article:20810734pubmed:meshHeadingpubmed-meshheading:20810734...lld:pubmed
pubmed-article:20810734pubmed:meshHeadingpubmed-meshheading:20810734...lld:pubmed
pubmed-article:20810734pubmed:meshHeadingpubmed-meshheading:20810734...lld:pubmed
pubmed-article:20810734pubmed:meshHeadingpubmed-meshheading:20810734...lld:pubmed
pubmed-article:20810734pubmed:meshHeadingpubmed-meshheading:20810734...lld:pubmed
pubmed-article:20810734pubmed:meshHeadingpubmed-meshheading:20810734...lld:pubmed
pubmed-article:20810734pubmed:meshHeadingpubmed-meshheading:20810734...lld:pubmed
pubmed-article:20810734pubmed:meshHeadingpubmed-meshheading:20810734...lld:pubmed
pubmed-article:20810734pubmed:meshHeadingpubmed-meshheading:20810734...lld:pubmed
pubmed-article:20810734pubmed:year2010lld:pubmed
pubmed-article:20810734pubmed:articleTitleAndes virus disrupts the endothelial cell barrier by induction of vascular endothelial growth factor and downregulation of VE-cadherin.lld:pubmed
pubmed-article:20810734pubmed:affiliationSpecial Pathogens Branch, G-14, Division of Viral and Rickettsial Diseases, National Center for Infectious Diseases, Centers for Disease Control and Prevention, 1600 Clifton Rd., Atlanta, GA 30333, USA.lld:pubmed
pubmed-article:20810734pubmed:publicationTypeJournal Articlelld:pubmed
entrez-gene:7422entrezgene:pubmedpubmed-article:20810734lld:entrezgene
entrez-gene:1003entrezgene:pubmedpubmed-article:20810734lld:entrezgene
http://linkedlifedata.com/r...entrezgene:pubmedpubmed-article:20810734lld:entrezgene
http://linkedlifedata.com/r...entrezgene:pubmedpubmed-article:20810734lld:entrezgene
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:20810734lld:pubmed